MetLife (NYSE: MET) investor files Rule 144 notice for small sale
Rhea-AI Filing Summary
MetLife-related accounts have filed a Rule 144 notice to sell a small block of MET common stock. The filing covers a proposed sale of 10 shares of common stock through Bernstein Institutional Services LLC, with an aggregate market value of 817.1, out of 658,891,656 shares outstanding, on or about 12/19/2025 on the NYSE.
The 10 shares to be sold were acquired by purchase from Citigroup Global Markets on 10/11/2021 and paid for in cash on 10/13/2021. The notice also lists prior sales over the past three months by various MetLife accounts and plan trusts, including small transactions such as 335 shares sold for 25,563.85 and 333 shares sold for 27,282.69.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for MET disclose?
The Form 144 filing for MET discloses a planned sale of 10 shares of common stock through Bernstein Institutional Services LLC, with an aggregate market value of 817.1, out of 658,891,656 shares outstanding, expected around 12/19/2025 on the NYSE.
What prior sales of the issuer’s common stock are disclosed for the past 3 months?
The notice lists several small prior sales of common stock over the past three months by MetLife-related accounts, including Separate Account SPI selling 335 shares for 25,563.85 on 12/01/2025 and MetLife 401k Plan Trust-Large Cap Equity Index selling 333 shares for 27,282.69 on 10/01/2025.
What representation does the seller make in signing the MET Form 144 notice?
By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and acknowledges that intentional misstatements or omissions constitute federal criminal violations.